Shares of Celgene Corp. (Nasdaq: CELG) plummeted $6.67 to $37.73 after the drug maker lowered its outlook.
Celgene Lowers Outlook
April 01, 2009 at 12:11 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.